{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:15Z","timestamp":1787003655928,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA234701"],"award-info":[{"award-number":["R21CA234701"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R56HL155582"],"award-info":[{"award-number":["R56HL155582"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy And Infectious Diseases","doi-asserted-by":"crossref","award":["U19AI067798"],"award-info":[{"award-number":["U19AI067798"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite advances in therapy, multiple myeloma (MM) largely remains incurable, emphasizing the need for new strategies to overcome drug resistance. Ferroptosis is an iron-dependent cell death pathway that may present a therapeutic vulnerability in MM, but its transcriptional regulation remains poorly understood. Retinoid X receptors (RXRs) are ligand-activated nuclear transcription factors that regulate metabolism, redox homeostasis, and immune signaling. In this study, we demonstrate that RXR signaling regulates ferroptosis. The selective third-generation RXR agonist IRX4204 significantly increased MM cells\u2019 susceptibility to ferroptotic stress and worked synergistically with ferroptosis inducers. Mechanistic studies showed that IRX4204 actively induces HMOX1 transcription via PPAR\u03b1-RXR\u03b1 binding and concurrently decreases GPX4 levels, leading to iron buildup, lipid peroxidation, and ferroptosis. Deleting HMOX1 using CRISPR abolished these effects, confirming HMOX1 as an essential effector. In vivo, IRX4204 enhanced lenalidomide\u2019s effectiveness, reduced tumor burden, extended survival, and elevated ferroptosis markers without added toxicity. Clinically, high HMOX1 expression correlates with improved overall survival in MM patients. These findings reveal a new RXR\u2013HMOX1\u2013GPX4 regulatory axis, establish RXR activation as a method to boost ferroptosis sensitivity, and support combining RXR agonists with ferroptosis-based treatments in MM.<\/jats:p>","DOI":"10.1038\/s41598-026-42123-9","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:08:41Z","timestamp":1773756521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IRX4204 sensitizes multiple myeloma to ferroptosis and improves lenalidomide efficacy through the HMOX1-GPX4 axis"],"prefix":"10.1038","volume":"16","author":[{"given":"Jian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Burcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhannan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail A.","family":"Nikiforov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidyasagar","family":"Vuligonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"42123_CR1","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s13346-022-01268-6","volume":"13","author":"J Metselaar","year":"2023","unstructured":"Metselaar, J. et al. A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma. Drug Deliv. Transl. Res. 13, 915\u2013923. https:\/\/doi.org\/10.1007\/s13346-022-01268-6 (2023).","journal-title":"Drug Deliv. Transl. Res."},{"key":"42123_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70980","volume":"14","author":"Q Zhou","year":"2025","unstructured":"Zhou, Q. et al. Tregs at diagnosis as a potential biomarker for predicting high-risk functionality in newly diagnosed multiple myeloma. Cancer Med. 14, e70980. https:\/\/doi.org\/10.1002\/cam4.70980 (2025).","journal-title":"Cancer Med."},{"key":"42123_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph13040374","volume":"13","author":"JW Gao","year":"2016","unstructured":"Gao, J. W. et al. Identification of haplotype tag single-nucleotide polymorphisms within the PPAR family genes and their clinical relevance in patients with major trauma. Int. J. Environ. Res. Public Health 13, 374. https:\/\/doi.org\/10.3390\/ijerph13040374 (2016).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"42123_CR4","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/jdi.13567","volume":"12","author":"F Akter","year":"2021","unstructured":"Akter, F., Tsuyama, T., Yoshizawa, T., Sobuz, S. U. & Yamagata, K. SIRT7 regulates lipogenesis in adipocytes through deacetylation of PPARgamma2. J. Diabetes Investig. 12, 1765\u20131774. https:\/\/doi.org\/10.1111\/jdi.13567 (2021).","journal-title":"J. Diabetes Investig."},{"key":"42123_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071687","author":"M Pajares","year":"2020","unstructured":"Pajares, M., A, I. R., Manda, G., Bosca, L. & Cuadrado, A. Inflammation in Parkinson\u2019s Disease: Mechanisms and Therapeutic Implications. Cells https:\/\/doi.org\/10.3390\/cells9071687 (2020).","journal-title":"Cells"},{"key":"42123_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12051122","author":"L Rutkowska","year":"2022","unstructured":"Rutkowska, L., Salachna, D., Lewandowski, K., Lewinski, A. & Gach, A. Familial partial lipodystrophy-literature review and report of a novel variant in PPARG expanding the spectrum of disease-causing alterations in FPLD3. Diagnostics (Basel) https:\/\/doi.org\/10.3390\/diagnostics12051122 (2022).","journal-title":"Diagnostics (Basel)"},{"key":"42123_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cells12151993","author":"J Wu","year":"2023","unstructured":"Wu, J., Wang, X., Zhang, M., Mathews, P. & Kang, Y. RXR agonists enhance lenalidomide anti-myeloma activity and T cell functions while retaining glucose-lowering effect. Cells https:\/\/doi.org\/10.3390\/cells12151993 (2023).","journal-title":"Cells"},{"key":"42123_CR8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025029950","author":"Z Yan","year":"2025","unstructured":"Yan, Z. et al. Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma. Blood https:\/\/doi.org\/10.1182\/blood.2025029950 (2025).","journal-title":"Blood"},{"key":"42123_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1212\/wnl.0000000000207730","volume":"101","author":"E Benarroch","year":"2023","unstructured":"Benarroch, E. What is the role of ferroptosis in neurodegeneration?. Neurology 101, 312\u2013319. https:\/\/doi.org\/10.1212\/wnl.0000000000207730 (2023).","journal-title":"Neurology"},{"key":"42123_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.psj.2023.103223","volume":"103","author":"Q Liu","year":"2024","unstructured":"Liu, Q. et al. N-carbamylglutamate supplementation induces functional egg production in layers by modulating liver transcriptome profiles. Poult. Sci. 103, 103223. https:\/\/doi.org\/10.1016\/j.psj.2023.103223 (2024).","journal-title":"Poult. Sci."},{"key":"42123_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101971","volume":"43","author":"Z Tang","year":"2021","unstructured":"Tang, Z. et al. HO-1-mediated ferroptosis as a target for protection against retinal pigment epithelium degeneration. Redox Biol. 43, 101971. https:\/\/doi.org\/10.1016\/j.redox.2021.101971 (2021).","journal-title":"Redox Biol."},{"key":"42123_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93834-4","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Solasodine suppresses nasopharyngeal carcinoma progression by inducing ferroptosis. Sci. Rep. 15, 17247. https:\/\/doi.org\/10.1038\/s41598-025-93834-4 (2025).","journal-title":"Sci. Rep."},{"key":"42123_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050735","author":"R Fernandez-Acosta","year":"2023","unstructured":"Fernandez-Acosta, R. et al. Molecular mechanisms of nemorosone-induced ferroptosis in cancer cells. Cells https:\/\/doi.org\/10.3390\/cells12050735 (2023).","journal-title":"Cells"},{"key":"42123_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-012615-044336","volume":"11","author":"L Wilsbacher","year":"2016","unstructured":"Wilsbacher, L. & McNally, E. M. Genetics of cardiac developmental disorders: Cardiomyocyte proliferation and growth and relevance to heart failure. Annu. Rev. Pathol. 11, 395\u2013419. https:\/\/doi.org\/10.1146\/annurev-pathol-012615-044336 (2016).","journal-title":"Annu. Rev. Pathol."},{"key":"42123_CR15","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1158\/1078-0432.CCR-23-3839","volume":"30","author":"CL Moyer","year":"2024","unstructured":"Moyer, C. L. et al. IRX4204 induces senescence and cell death in HER2-positive breast cancer and synergizes with anti-HER2 therapy. Clin. Cancer Res. 30, 2558\u20132570. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-3839 (2024).","journal-title":"Clin. Cancer Res."},{"key":"42123_CR16","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1182\/blood.2020005628","volume":"137","author":"G Thangavelu","year":"2021","unstructured":"Thangavelu, G. et al. Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responses. Blood 137, 1090\u20131103. https:\/\/doi.org\/10.1182\/blood.2020005628 (2021).","journal-title":"Blood"},{"key":"42123_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1391946","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Qingxuan runmu yin alleviates dry eye disease via inhibition of the HMOX1\/HIF-1 pathway affecting ferroptosis. Front. Pharmacol. 15, 1391946. https:\/\/doi.org\/10.3389\/fphar.2024.1391946 (2024).","journal-title":"Front. Pharmacol."},{"key":"42123_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114445","volume":"43","author":"P Peng","year":"2024","unstructured":"Peng, P. et al. Pro-survival signaling regulates lipophagy essential for multiple myeloma resistance to stress-induced death. Cell Rep. 43, 114445. https:\/\/doi.org\/10.1016\/j.celrep.2024.114445 (2024).","journal-title":"Cell Rep."},{"key":"42123_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/bjh.17080","volume":"193","author":"S Mithraprabhu","year":"2021","unstructured":"Mithraprabhu, S. et al. Phase II trial of single-agent panobinostat consolidation improves responses after sub-optimal transplant outcomes in multiple myeloma. Br. J. Haematol. 193, 160\u2013170. https:\/\/doi.org\/10.1111\/bjh.17080 (2021).","journal-title":"Br. J. Haematol."},{"key":"42123_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081913","author":"L Li","year":"2025","unstructured":"Li, L., Liu, X., Si, Z. & Wang, X. Epigenetic mechanisms governing Nrf2 expression and its role in ferroptosis. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines13081913 (2025).","journal-title":"Biomedicines"},{"key":"42123_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101418","volume":"30","author":"D Shin","year":"2020","unstructured":"Shin, D., Lee, J., You, J. H., Kim, D. & Roh, J. L. Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer. Redox Biol. 30, 101418. https:\/\/doi.org\/10.1016\/j.redox.2019.101418 (2020).","journal-title":"Redox Biol."},{"key":"42123_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.834681","volume":"12","author":"H Lan","year":"2022","unstructured":"Lan, H., Gao, Y., Zhao, Z., Mei, Z. & Wang, F. Ferroptosis: Redox imbalance and hematological tumorigenesis. Front. Oncol. 12, 834681. https:\/\/doi.org\/10.3389\/fonc.2022.834681 (2022).","journal-title":"Front. Oncol."},{"key":"42123_CR23","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.chembiol.2020.03.005","volume":"27","author":"DA Armenta","year":"2020","unstructured":"Armenta, D. A. & Dixon, S. J. Investigating nonapoptotic cell death using chemical biology approaches. Cell Chem. Biol. 27, 376\u2013386. https:\/\/doi.org\/10.1016\/j.chembiol.2020.03.005 (2020).","journal-title":"Cell Chem. Biol."},{"key":"42123_CR24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","volume":"82","author":"R Rodriguez","year":"2022","unstructured":"Rodriguez, R., Schreiber, S. L. & Conrad, M. Persister cancer cells: Iron addiction and vulnerability to ferroptosis. Mol. Cell. 82, 728\u2013740. https:\/\/doi.org\/10.1016\/j.molcel.2021.12.001 (2022).","journal-title":"Mol. Cell."},{"key":"42123_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00553-6","volume":"7","author":"M Mazhar","year":"2021","unstructured":"Mazhar, M. et al. Implication of ferroptosis in aging. Cell Death Discov. 7, 149. https:\/\/doi.org\/10.1038\/s41420-021-00553-6 (2021).","journal-title":"Cell Death Discov."},{"key":"42123_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02669-5","volume":"11","author":"YT Wang","year":"2025","unstructured":"Wang, Y. T. et al. Defective lipid droplet biogenesis exacerbates oleic acid-induced cellular homeostasis disruption and ferroptosis in mouse cardiac endothelial cells. Cell Death Discov. 11, 374. https:\/\/doi.org\/10.1038\/s41420-025-02669-5 (2025).","journal-title":"Cell Death Discov."},{"key":"42123_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108561","volume":"252","author":"AS Leal","year":"2023","unstructured":"Leal, A. S., Hung, P. Y., Chowdhury, A. S. & Liby, K. T. Retinoid X receptor agonists as selective modulators of the immune system for the treatment of cancer. Pharmacol. Ther. 252, 108561. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108561 (2023).","journal-title":"Pharmacol. Ther."},{"key":"42123_CR28","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1007\/s11010-023-04914-w","volume":"479","author":"D Macejova","year":"2024","unstructured":"Macejova, D. et al. Triphenyltin isoselenocyanate: A novel nuclear retinoid X receptor ligand with antiproliferative and cytotoxic properties in cell lines derived from human breast cancer. Mol. Cell. Biochem. 479, 3091\u20133106. https:\/\/doi.org\/10.1007\/s11010-023-04914-w (2024).","journal-title":"Mol. Cell. Biochem."},{"key":"42123_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11121915","author":"OD Martino","year":"2019","unstructured":"Martino, O. D. & Welch, J. S. Retinoic acid receptors in acute myeloid leukemia therapy. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers11121915 (2019).","journal-title":"Cancers (Basel)"},{"key":"42123_CR30","doi-asserted-by":"publisher","unstructured":"Gangwar, S. K. et al. Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects. Pharmaceuticals (Basel). 15 https:\/\/doi.org\/10.3390\/ph15050624 (2022).","DOI":"10.3390\/ph15050624"},{"key":"42123_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12640-015-9572-6","volume":"29","author":"A Wnuk","year":"2016","unstructured":"Wnuk, A. et al. The Crucial Involvement of Retinoid X Receptors in DDE Neurotoxicity. Neurotox. Res. 29, 155\u2013172. https:\/\/doi.org\/10.1007\/s12640-015-9572-6 (2016).","journal-title":"Neurotox. Res."},{"key":"42123_CR32","doi-asserted-by":"publisher","first-page":"1254612","DOI":"10.3389\/fcell.2023.1254612","volume":"11","author":"K Lavudi","year":"2023","unstructured":"Lavudi, K. et al. Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers. Front. Cell. Dev. Biol. 11, 1254612. https:\/\/doi.org\/10.3389\/fcell.2023.1254612 (2023).","journal-title":"Front. Cell. Dev. Biol."},{"key":"42123_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1379967","volume":"15","author":"S Yeudall","year":"2024","unstructured":"Yeudall, S., Upchurch, C. M. & Leitinger, N. The clinical relevance of heme detoxification by the macrophage heme oxygenase system. Front. Immunol. 15, 1379967. https:\/\/doi.org\/10.3389\/fimmu.2024.1379967 (2024).","journal-title":"Front. Immunol."},{"key":"42123_CR34","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.7150\/ijbs.80590","volume":"19","author":"KH Lu","year":"2023","unstructured":"Lu, K. H., Lu, P. W., Lu, E. W., Lin, C. W. & Yang, S. F. Curcumin and its analogs and carriers: Potential therapeutic strategies for human osteosarcoma. Int. J. Biol. Sci. 19, 1241\u20131265. https:\/\/doi.org\/10.7150\/ijbs.80590 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"42123_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5309286","volume":"2018","author":"C Jia","year":"2018","unstructured":"Jia, C. et al. Differential effects of three techniques for hepatic vascular exclusion during resection for liver cirrhosis on hepatic ischemia-reperfusion injury in rats. Gastroenterol. Res. Pract. 2018, 5309286. https:\/\/doi.org\/10.1155\/2018\/5309286 (2018).","journal-title":"Gastroenterol. Res. Pract."},{"key":"42123_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-017-0629-y","volume":"112","author":"M Tomczyk","year":"2017","unstructured":"Tomczyk, M. et al. Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice. Basic Res. Cardiol. 112, 39. https:\/\/doi.org\/10.1007\/s00395-017-0629-y (2017).","journal-title":"Basic Res. Cardiol."},{"key":"42123_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206798","volume":"10","author":"C Zheng","year":"2023","unstructured":"Zheng, C. et al. Donafenib and GSK-J4 synergistically induce ferroptosis in liver cancer by upregulating HMOX1 expression. Adv. Sci. (Weinh.). 10, e2206798. https:\/\/doi.org\/10.1002\/advs.202206798 (2023).","journal-title":"Adv. Sci. (Weinh.)."},{"key":"42123_CR38","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49503","author":"RH Pek","year":"2019","unstructured":"Pek, R. H. et al. Hemozoin produced by mammals confers heme tolerance. Elife https:\/\/doi.org\/10.7554\/eLife.49503 (2019).","journal-title":"Elife"},{"key":"42123_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103705","volume":"84","author":"C Hu","year":"2025","unstructured":"Hu, C. et al. Crosstalk of autophagy and ferroptosis in cardiovascular diseases: From pathophysiology to novel therapy. Redox Biol 84, 103705. https:\/\/doi.org\/10.1016\/j.redox.2025.103705 (2025).","journal-title":"Redox Biol"},{"key":"42123_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/7222462","volume":"2023","author":"KK Gomes","year":"2023","unstructured":"Gomes, K. K. Increased iron levels and oxidative stress mediate age-related impairments in male and female Drosophila melanogaster. Oxid. Med. Cell. Longev. 2023, 7222462. https:\/\/doi.org\/10.1155\/2023\/7222462 (2023).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"42123_CR41","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.freeradbiomed.2013.06.030","volume":"65","author":"DN Hauser","year":"2013","unstructured":"Hauser, D. N., Dukes, A. A., Mortimer, A. D. & Hastings, T. G. Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4. Free Radic. Biol. Med. 65, 419\u2013427. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.06.030 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"42123_CR42","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80647","author":"C Du","year":"2023","unstructured":"Du, C. Neutral amino acid transporter SLC38A2 protects renal medulla from hyperosmolarity-induced ferroptosis. Elife https:\/\/doi.org\/10.7554\/eLife.80647 (2023).","journal-title":"Elife"},{"key":"42123_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03373-7","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang, L., Zeng, L., Zhang, J., He, Z. & Liu, X. Screening drugs of Anemoside B4 for MFAP4 expression in osteosarcoma in PDTX to increase personalized medicine. Discov. Oncol. 16, 1527. https:\/\/doi.org\/10.1007\/s12672-025-03373-7 (2025).","journal-title":"Discov. Oncol."},{"key":"42123_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01550-6","volume":"25","author":"J Liang","year":"2025","unstructured":"Liang, J. Donafenib activates the p53 signaling pathway in hepatocellular carcinoma, induces ferroptosis, and enhances cell apoptosis. Clin. Exp. Med. 25, 29. https:\/\/doi.org\/10.1007\/s10238-024-01550-6 (2025).","journal-title":"Clin. Exp. Med."},{"key":"42123_CR45","doi-asserted-by":"publisher","first-page":"13031","DOI":"10.1007\/s00210-025-04149-0","volume":"398","author":"G Gupta","year":"2025","unstructured":"Gupta, G. et al. Caspase-independent cell death in lung cancer: From mechanisms to clinical applications. Naunyn Schmiedebergs Arch. Pharmacol. 398, 13031\u201313048. https:\/\/doi.org\/10.1007\/s00210-025-04149-0 (2025).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"42123_CR46","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000042146","volume":"104","author":"X Yang","year":"2025","unstructured":"Yang, X. & Wang, Y. Prognosis stratification of patients with breast cancer based on disulfidptosis and ferroptosis. Medicine (Baltimore) 104, e42146. https:\/\/doi.org\/10.1097\/MD.0000000000042146 (2025).","journal-title":"Medicine (Baltimore)"},{"key":"42123_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.fochx.2023.101038","volume":"20","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. Proteomic and metabolomic analysis of ageing beef exudate to determine that iron metabolism enhances muscle protein and lipid oxidation. Food Chem. X 20, 101038. https:\/\/doi.org\/10.1016\/j.fochx.2023.101038 (2023).","journal-title":"Food Chem. X"},{"key":"42123_CR48","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei, G., Zhuang, L. & Gan, B. Targeting ferroptosis as a vulnerability in cancer. Nat. Rev. Cancer 22, 381\u2013396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"42123_CR49","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan, V. S. et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547, 453\u2013457. https:\/\/doi.org\/10.1038\/nature23007 (2017).","journal-title":"Nature"},{"key":"42123_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang, C., Liu, X., Jin, S., Chen, Y. & Guo, R. Ferroptosis in cancer therapy: A novel approach to reversing drug resistance. Mol. Cancer 21, 47. https:\/\/doi.org\/10.1186\/s12943-022-01530-y (2022).","journal-title":"Mol. Cancer"},{"key":"42123_CR51","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.trecan.2021.04.005","volume":"7","author":"X Chen","year":"2021","unstructured":"Chen, X., Kang, R., Kroemer, G. & Tang, D. Targeting ferroptosis in pancreatic cancer: A double-edged sword. Trends Cancer 7, 891\u2013901. https:\/\/doi.org\/10.1016\/j.trecan.2021.04.005 (2021).","journal-title":"Trends Cancer"},{"key":"42123_CR52","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2020.02.005","volume":"27","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Autophagy-dependent ferroptosis: Machinery and regulation. Cell Chem. Biol. 27, 420\u2013435. https:\/\/doi.org\/10.1016\/j.chembiol.2020.02.005 (2020).","journal-title":"Cell Chem. Biol."},{"key":"42123_CR53","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia, B., Vandenabeele, P. & Vanden Berghe, T. Targeting ferroptosis to iron out cancer. Cancer Cell 35, 830\u2013849. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.002 (2019).","journal-title":"Cancer Cell"},{"key":"42123_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-022-00329-3","volume":"11","author":"S Jabbar","year":"2022","unstructured":"Jabbar, S. et al. Thioredoxin-1 regulates self-renewal and differentiation of murine hematopoietic stem cells through p53 tumor suppressor. Exp. Hematol. Oncol. 11, 83. https:\/\/doi.org\/10.1186\/s40164-022-00329-3 (2022).","journal-title":"Exp. Hematol. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42123-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42123-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42123-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:16:31Z","timestamp":1781640991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42123-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42123"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42123-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13832"}}